The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC).
 
Sasha E. Stanton
Consulting or Advisory Role - Sanford Burnham Prebys
Research Funding - IMV (Inst)
 
Lisa Diana MacDonald
Employment - IMV
Stock and Other Ownership Interests - IMV
Patents, Royalties, Other Intellectual Property - Co-inventor on several company-owned (IMV Inc.) patents
 
Staci L. Mellinger
No Relationships to Disclose
 
Nicole Moxon
Consulting or Advisory Role - Seagen
 
Tracy Kelly
No Relationships to Disclose
 
Heather Anne Hirsch
Employment - Crispr Therapeutics; IMV
Leadership - IMV
Stock and Other Ownership Interests - Crispr Therapeutics
 
Stephan Fiset
Employment - IMV; Medicago; Medicago
Stock and Other Ownership Interests - IMV
Patents, Royalties, Other Intellectual Property - Patent pending for IMV for our lead anti-cancer product
Travel, Accommodations, Expenses - IMV
 
Kristina Hoot Young
Research Funding - Bristol-Myers Squibb; IMV (Inst); Lilly
Patents, Royalties, Other Intellectual Property - hold patent
 
David B. Page
Honoraria - Novartis
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics; Genentech; Puma Biotechnology
Speakers' Bureau - Genentech/Roche; Novartis
Research Funding - Bristol-Myers Squibb (Mexico); Brooklyn ImmunoTherapeutics; IMV (Inst); MedImmune (Inst); Merck
Expert Testimony - Philips Healthcare